Skip to main content

Advertisement

SpringerLink
Log in

Cytomegalovirus-associated meningoradiculoneuritis after treatment of mantle cell lymphoma with a combination of chemotherapy and rituximab

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Boye J, Elter T, Engert A (2003) An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. Ann Oncol 14:520–535

    Google Scholar 

  2. Bermudez A, Marco F, Conde E, Mazo E, Recio M, Zubizarreta A (2000) Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma. Haematologica 85:894–895

    Google Scholar 

  3. Suzan F, Ammor M, Ribrag V (2001) Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder. N Engl J Med 345:1000

    Article  CAS  Google Scholar 

  4. Goldberg SL, Pecora AL, Alter RS, Kroll MS, Rowley SD, Waintraub SE, Imrit K, Preti RA (2002) Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood 99:1486–1488

    Google Scholar 

  5. Quartier P, Tournilhac O, Archimbaud C, Lazaro L, Chaleteix C, Millet P, Peigue-Lafeuille H, Blanche S, Fischer A, Casanova JL, Travade P, Tardieu M (2003) Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment. Clin Infect Dis 36:e47–e49

    Google Scholar 

  6. Hernandez JA, Diloy R, Salat D, del Rio N, Martinez X, Castellvi JM (2003) Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab. Haematologica 88:ECR22

    Google Scholar 

  7. Song KW, Mollee P, Patterson B, Brien W, Crump M (2002) Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma. Br J Haematol 119:125–127

    Google Scholar 

  8. Tsutsumi Y, Tanaka J, Kawamura T, Miura T, Kanamori H, Obara S, Asaka M, Imamura M, Masauzi N (2004) Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin’s lymphoma. Ann Hematol 83:58–60

    Google Scholar 

  9. Flohr T, Hess GR, Kreiter S, Meyer RG, Huber C, Derigs G (2000) Immune reconstitution after autologous CD34-positive selected peripheral blood stem cell transplantation combined with rituximab for refractory B-cell non-Hodgkin’s lymphoma. Blood 96:709a (abstract)

    Google Scholar 

  10. Horwitz SM, Breslin S, Negrin RS, Stockerl-Goldstein KE, Johnston LJ, Shizuru JA, Taylor T, Brown BW, Blume KG, Horning SJ (2000) Adjuvant rituximab after autologous peripheral blood stem cell transplant results in delayed immune reconstitution with increase in infectious complications. Blood 96:707a (abstract)

    Google Scholar 

  11. McLaughlin P, Grillo-Lopez AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen D, Dallaire BK (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 16:2825–2833

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology (E.A. Biodiversity and Microbial Ecology no. 3882), University Hospital Morvan, 2 avenue Foch, 29609, Brest Cedex, France

    S. Vallet, A. Tran, M. C. Legrand-Quillien & V. Narbonne

  2. Department of Haematology/Oncology, University Hospital Morvan, Brest, France

    A. Tempescul & C. Berthou

Authors
  1. S. Vallet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Tempescul
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Tran
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. C. Legrand-Quillien
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Narbonne
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Berthou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Vallet.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vallet, S., Tempescul, A., Tran, A. et al. Cytomegalovirus-associated meningoradiculoneuritis after treatment of mantle cell lymphoma with a combination of chemotherapy and rituximab. Ann Hematol 84, 545–547 (2005). https://doi.org/10.1007/s00277-005-1038-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-005-1038-0

Keywords

Search

Navigation